Replies to post #31918 on ViaDerma Inc (VDRM)

[retired early]

My initial email to them is on the bottom and their response above.

ViaDerma Investor Relations <[e-mail]>
Today, 7:29 PMYou

K'''

Let me clairify the breakdown of the VDRM/Biogenx deal. The 5% is a licensing fee to VDRM off the top. After that the profits are split 50%-50%. So net split is ViaDerma 55% and Biogenx 45%. That is only for sales generated by Biogenx. As for all sales generated by VDRM have different arrangements giving VDRM as much 75% share of sales. The 25% ownership is really meaningless because Biogenx ONLY receives money for Biogenx sales. They make nothing on all non-Biogenx generated sales.

I hope this clarifies.
---
ViaDerma Investor Relations
310-734-6111


On 2017-12-13 19:14, K== M======= wrote:
>
> How could THE DR. TAKE SHAREHOLDER MONEY to start up production and leave us only 5%. Biogenx should be a subsidiary to Viaderma.
>
>
>
> Sounds like a scam to us shareholders and it will be explored more in depth. I own 14 million shares.
>

>
>
>
> Biogenx, Inc. is minority owned (25%) by the Company's President, Dr. Chris Otiko. Did we get scammed or what?
>
>
>
> K=== M]]]]]]]]
>
> Englewood FL.